Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Aimmune Therap (AIMT)

Aimmune Therap (AIMT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
34.49 -0.10 (-0.29%) 10/12/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 34.49 unch (unch) -
Quote Overview for Mon, Oct 12th, 2020
Day Low
34.48
Day High
34.56
Open 34.56
Previous Close 34.59 34.59
Volume 987,200 987,200
Avg Vol 1,628,530 1,628,530
Stochastic %K 82.92% 82.92%
Weighted Alpha -31.00 -31.00
5-Day Change +0.05 (+0.15%) +0.05 (+0.15%)
52-Week Range 10.09 - 37.00 10.09 - 37.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,257,370
  • Shares Outstanding, K 65,450
  • Annual Sales, $ 0 K
  • Annual Income, $ -248,500 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.76
  • Price/Sales 3,892.02
  • Price/Cash Flow N/A
  • Price/Book 12.55
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.33
  • Most Recent Earnings $-1.06 on 07/30/20
  • Next Earnings Date 11/04/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.99
  • Number of Estimates 7
  • High Estimate -0.88
  • Low Estimate -1.23
  • Prior Year -1.03
  • Growth Rate Est. (year over year) +3.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.21 +0.82%
on 09/14/20
Period Open: 34.20
34.59 -0.29%
on 10/09/20
+0.29 (+0.85%)
since 09/11/20
3-Month
11.82 +191.79%
on 08/28/20
Period Open: 15.68
34.59 -0.29%
on 10/09/20
+18.81 (+119.96%)
since 07/10/20
52-Week
10.09 +241.82%
on 03/17/20
Period Open: 24.55
37.00 -6.78%
on 01/16/20
+9.94 (+40.49%)
since 10/11/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Company's characterized oral desensitization immunotherapy includes AR101, a product for the treatment of peanut allergy in children and...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 34.59
1st Resistance Point 34.54
Last Price 34.49
1st Support Level 34.46
2nd Support Level 34.43
3rd Support Level N/A

See More

52-Week High 37.00
Last Price 34.49
Fibonacci 61.8% 26.72
Fibonacci 50% 23.55
Fibonacci 38.2% 20.37
52-Week Low 10.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro